Leidos has launched HeadWay Dispatch™, a platform designed to help organizations govern AI agents from multiple vendors by providing visibility, control, and accountability over their actions. The platform allows organizations to monitor which AI agents are active, set boundaries on their autonomous actions, and maintain tamper-evident records of decisions to ensure human oversight and accountability. It supports vendor flexibility, faster operator decisions, and enhanced security by protecting credentials. Leidos plans to add features tailoring operator views and coordinating AI agents under common policies, also ensuring controls work even if network connections fail. This platform aids federal agencies in meeting AI governance requirements and helps organizations maintain control as AI autonomy grows.
Leidos' new HeadWay Dispatch platform for AI agent oversight is the subject, with Pluang's Technology sector data providing market context. Of 150 priced US tech stocks on Pluang, 77 rose and 66 fell as of Nov 04, 2026 20:01 WIB. Notable movers include CIFR at USD 7.10 with a -12.56% change, SWKS at USD 75.44 down -11.66%, and BTDR at USD 6.24 down -9.83%.
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...
The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...
Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...
Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...
